These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21899493)

  • 21. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular shape analysis of antioxidant and squalene synthase inhibitory activities of aromatic tetrahydro-1,4-oxazine derivatives.
    Roy K; Mitra I; Saha A
    Chem Biol Drug Des; 2009 Nov; 74(5):507-16. PubMed ID: 19793182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of polyhydroxybenzophenones as α-glucosidase inhibitors.
    Hu X; Xiao Y; Wu J; Ma L
    Arch Pharm (Weinheim); 2011 Feb; 344(2):71-7. PubMed ID: 21290422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding mechanism and synergetic effects of xanthone derivatives as noncompetitive α-glucosidase inhibitors: a theoretical and experimental study.
    Liu Y; Ma L; Chen WH; Park H; Ke Z; Wang B
    J Phys Chem B; 2013 Oct; 117(43):13464-71. PubMed ID: 24083955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
    Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases.
    Moorthy NS; Ramos MJ; Fernandes PA
    Mini Rev Med Chem; 2012 Jul; 12(8):713-20. PubMed ID: 22512574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
    Puntambekar D; Giridhar R; Yadav MR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the novel alpha-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues.
    Dai GF; Xu HW; Wang JF; Liu FW; Liu HM
    Bioorg Med Chem Lett; 2006 May; 16(10):2710-3. PubMed ID: 16504503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J; Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2170-9. PubMed ID: 14632469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of α-glucosidase and α-amylase by diaryl derivatives of imidazole-thione and 1,2,4-triazole-thiol.
    Balba M; El-Hady NA; Taha N; Rezki N; El Ashry el SH
    Eur J Med Chem; 2011 Jun; 46(6):2596-601. PubMed ID: 21497424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase.
    Xing L; Goulet R; Johnson K
    J Chem Inf Model; 2011 Jul; 51(7):1582-92. PubMed ID: 21615155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors.
    Ekins S; Bravi G; Binkley S; Gillespie JS; Ring BJ; Wikel JH; Wrighton SA
    Drug Metab Dispos; 2000 Aug; 28(8):994-1002. PubMed ID: 10901712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo sampling and multivariate adaptive regression splines as tools for QSAR modelling of HIV-1 reverse transcriptase inhibitors.
    Alamdari RF; Mani-Varnosfaderani A; Asadollahi-Baboli M; Khalafi-Nezhad A
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):665-82. PubMed ID: 22746992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.